Intel Stock Surges as BofA Projects Strong Growth, Sees $6+ EPS by 2030
BofA boosts Intel to Buy, citing AI agent CPU boom and improved manufacturing outlook.
Already have an account? Sign in.
BofA boosts Intel to Buy, citing AI agent CPU boom and improved manufacturing outlook.
Adial Pharmaceuticals acquires Azora Therapeutics and raises up to $64 million to advance AT177, a novel colon-targeted therapy for ulcerative colitis. Phase 1 studies planned for mid-2027.
Analysts initiate coverage with Buy ratings on Sensei (SNSE), Septerna (SEPN), Kazia (KZIA), NervGen (NGEN), and Sutro (STRO).
Beijing targets misleading 618 deals by JD, PDD, Alibaba; stocks fall as regulators curb subsidy wars and unclear discounts.